Literature DB >> 17559600

Why people do not take their psychotropic drugs as prescribed: results of the 2000 National Psychiatric Morbidity Survey.

C Cooper1, P Bebbington, M King, T Brugha, H Meltzer, D Bhugra, R Jenkins.   

Abstract

OBJECTIVE: We examined the prevalence and determinants of the reasons given for non-adherence to psychiatric medication in a representative community survey.
METHOD: We used data for all participants taking oral psychotropic medication (n = 634) from the 2000 British Survey of National Psychiatric Morbidity.
RESULTS: Of participants interviewed, 217 (34.2%) reported incomplete adherence to their psychiatric medication. Reasons given included forgetting, losing, running out (37.4%); thinking medication unnecessary (24.6%); reluctance to take drugs (18.9%) and side-effects (14.2%). Those giving forgetfulness or side-effects as reasons were younger. Side-effects were reported more frequently by people with a lower IQ or with psychosis. Those taking Selective Serotonin Reuptake Inhibitors were more likely to forget to take their medication.
CONCLUSION: Two-fifths of people reported that missing their medication was a decision taken because they did not want it or think it necessary. Side-effects are a relatively uncommon reason for under-medication. Our results have implications for interventions to assist adherence.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17559600     DOI: 10.1111/j.1600-0447.2006.00974.x

Source DB:  PubMed          Journal:  Acta Psychiatr Scand        ISSN: 0001-690X            Impact factor:   6.392


  12 in total

1.  Side-effects of SSRIs disrupt multimodal treatment for pediatric OCD in a randomized-controlled trial.

Authors:  Adam M Reid; Joseph P H McNamara; Tanya K Murphy; Andrew G Guzick; Eric A Storch; Wayne K Goodman; Gary R Geffken; Regina Bussing
Journal:  J Psychiatr Res       Date:  2015-10-14       Impact factor: 4.791

2.  Patients with treatment-resistant insomnia taking nightly prescription medications for sleep: a retrospective assessment of diagnostic and treatment variables.

Authors:  Barry Krakow; Victor A Ulibarri; Edward A Romero
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2010

3.  Impact of treatment success on health service use and cost in depression: longitudinal database analysis.

Authors:  Sarah Byford; Barbara Barrett; Nicolas Despiégel; Alan Wade
Journal:  Pharmacoeconomics       Date:  2011-02       Impact factor: 4.981

4.  Ten ways to improve the treatment of depression and anxiety in adults.

Authors:  Boadie W Dunlop; Kelly Scheinberg; Anne L Dunlop
Journal:  Ment Health Fam Med       Date:  2013-09

5.  Study protocol for a randomized controlled trial comparing mindfulness-based cognitive therapy with maintenance anti-depressant treatment in the prevention of depressive relapse/recurrence: the PREVENT trial.

Authors:  Willem Kuyken; Sarah Byford; Richard Byng; Tim Dalgleish; Glyn Lewis; Rod Taylor; Edward R Watkins; Rachel Hayes; Paul Lanham; David Kessler; Nicola Morant; Alison Evans
Journal:  Trials       Date:  2010-10-20       Impact factor: 2.279

6.  Adverse drug reaction monitoring in psychiatry out-patient department of an Indian teaching hospital.

Authors:  Gairik Sengupta; Subhrojyoti Bhowmick; Avijit Hazra; Ananya Datta; Musfikur Rahaman
Journal:  Indian J Pharmacol       Date:  2011-02       Impact factor: 1.200

7.  Antidepressant dosage taken by patients with bipolar disorder: factors associated with irregularity.

Authors:  Rita Bauer; Tasha Glenn; Martin Alda; Kemal Sagduyu; Wendy Marsh; Paul Grof; Rodrigo Munoz; Greg Murray; Philipp Ritter; Ute Lewitzka; Emanuel Severus; Peter C Whybrow; Michael Bauer
Journal:  Int J Bipolar Disord       Date:  2013-12-09

8.  Efficacy, tolerability, and safety of oral paliperidone extended release in the treatment of schizophrenia: a 24-week, open-label, prospective switch study in different settings in Taiwan.

Authors:  Ching-Yen Chen; Tze-Chun Tang; Tzu-Ting Chen; Ya Mei Bai; Huei-Huang Tsai; Hou-Liang Chen; Chun-Jen Huang; Chih-Ken Chen; Chun-Chih Chen; Mei-Chun Hsiao; Chia-Yih Liu; Hong-Shiow Yeh; Nan-Ying Chiu; Cheng-Chen Hsiao; Cheng-Sheng Chen; Tung-Ping Su
Journal:  Neuropsychiatr Dis Treat       Date:  2018-03-08       Impact factor: 2.570

9.  Natural Medicines for Psychotic Disorders: A Systematic Review.

Authors:  H J Rogier Hoenders; Agna A Bartels-Velthuis; Nina K Vollbehr; Richard Bruggeman; Henderikus Knegtering; Joop T V M de Jong
Journal:  J Nerv Ment Dis       Date:  2018-02       Impact factor: 2.254

Review 10.  Shared decision making for psychiatric medication management: beyond the micro-social.

Authors:  Nicola Morant; Emma Kaminskiy; Shulamit Ramon
Journal:  Health Expect       Date:  2015-08-10       Impact factor: 3.377

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.